These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11319763)

  • 1. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
    Nakamura M; Saito H; Ebinuma H; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Ishii H
    J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
    Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
    Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
    Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP
    Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
    Zeng XL; Tu ZG
    Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
    Kaneko F; Saito H; Saito Y; Wakabayashi K; Nakamoto N; Tada S; Suzuki H; Tsunematsu S; Kumagai N; Ishii H
    Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
    Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
    Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
    Wang CT; Meng M
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):927-9. PubMed ID: 17650409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
    Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
    Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
    Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells.
    Woo HJ; Lee SJ; Choi BT; Park YM; Choi YH
    Exp Mol Pathol; 2007 Feb; 82(1):77-84. PubMed ID: 16574101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
    Choi YH
    Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.